Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease

Experimental Neurology

Volumn 183, Issue 2, 2003, Pages 700-704

  Ryu, Jae K ^a   Kim, Seung U ^a,b   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Ajou University   (South Korea)

Author keywords

Huntington's disease; Lactate; Neuroprotection; Quinolinic acid; Sodium pyruvate; Striatal neurons

Indexed keywords

PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MEGADOSE; EXPERIMENTAL MODEL; GLYCOLYSIS; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; INJECTION SITE; INTERNEURON; MOTONEURON NUCLEUS; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

EID: 0141560478     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00214-0     Document Type: Article

References (24)

1. Andreassen O.A., Ferrante R.J., Huang H.M., Dedeoglu A., Park L., Ferrante K.L., Kwon J., Borchelt D.R., Ross C.A., Gibson G.E., Beal M.F. Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease. Ann. Neurol. 50:2001;112-117.
2. Araujo D.M., Cherry S.R., Tatsukawa K.J., Toyokuni T., Kornblum H.I. Deficits in striatal dopamine D (2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease. Exp. Neurol. 166:2000;287-297.
3. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
4. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
5. Bordelon Y.M., Chesselet M.F., Erecinska M., Silver I.A. Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo. Neuroscience. 83:1998;459-469.
6. Bordelon Y.M., Chesselet M.F., Nelson D., Welsh F., Erecinska M. Energetic dysfunction in quinolinic acid-lesioned rat striatum. J. Neurochem. 69:1997;1629-1639.
7. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., Bird E.D., Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease selective vulnerability of the basal ganglia . Ann. Neurol. 41:1997;646-653.
8. Butterworth J., Yates C.M., Reynolds G.P. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases. J. Neurol. Sci. 67:1985;161-171.
9. Desagher S., Glowinski J., Prémont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17:1997;9060-9067.
10. Giandomenico A.R., Cerniglia G.E., Biaglow J.E., Stevens C.W., Koch C.J. The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radic. Biol. Med. 23:1997;426-434.
11. Gu M., Gash M.T., Mann V.M., Javoy-Agid F., Cooper J.M., Schapira A.H. Mitochondrial defect in Huntigton's disease caudate nucleus. Ann. Neurol. 39:1996;385-389.
12. Guidetti P., Charles V., Chen E.Y., Reddy P.H., Kordower J.H., Whetsell W.O. Jr, Schwarcz R., Tagle D.A. Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp. Neurol. 169:2001;340-350.
13. Harper P.S. Huntington's Disease. 1996;W.B. Saunders, London.
14. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
15. Lee J.Y., Kim Y.H., Koh J.Y. Protection by pyruvate against transient forebrain ischemia in rats. J. Neurosci. 21:2001;RC171.
16. Matthews R.T., Yang L., Jenkins B.G., Ferrante R.J., Rosen B.R., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18:1998;156-163.
17. Maus M., Marin P., Israel M., Glowinski J., Premont J. Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity. Eur. J. Neurosci. 11:1999;3215-3224.
18. Nakao N., Grasbon-Frodl E.M., Widner H., Brundin P. Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience. 73:1996;185-200.
19. Oldendorf W.H. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am. J. Physiol. 224:1973;1450-1453.
20. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, San Diego.
21. + and inhibition of glycolysis . J. Neurosci. 20:2000;3139-3146.
22. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16:1996;877-885.
23. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Jr. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
24. Wang X.F., Cynader M.S. Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J. Neurosci. 21:2001;3322-3331.